Sodium trimetaphosphate
Based on 1 Customer Validation
Sodium trimetaphosphate (Trisodium cyclo-triphosphate) is an orally active, multifunctional compound. Sodium trimetaphosphate serves as a buffer and chelating agent in cosmetics, a starch modifier in food, and can also act as a bone imaging agent. Sodium trimetaphosphate undergoes alkaline hydrolysis, with the rate-limiting first step producing sodium tripolyphosphate; the conversion rate is low when sodium carbonate or silicate is used. Sodium trimetaphosphate can be used in caries-related research.
For research use only. We do not sell to patients.
- CAS No.: 7785-84-4
- Formula: Na3P3O9
- Molecular Weight:305.89
-
Storage:
Store at room temperature, keep dry and cool.
In solvent -80°C, 1 year , -20°C, 6 months
Biological Activity
Sodium Trimetaphosphate (Trisodium cyclo-triphosphate) (150 min) does not undergo significant hydrolysis in heparinized rabbit blood incubated at 38°C, but induces increased orthophosphate leakage from blood cells compared to controls[2].
Sodium trimetaphosphate undergoes alkaline hydrolysis to sodium tripolyphosphate in aqueous solutions via a rate-controlled consecutive mechanism, with reaction rate constants ranging from 0.0046 to 0.525 (Mole/L)-1(Min)-1, and rates increasing with solids concentration, NaOH ratio, temperature, and sodium sulfate addition[3].
Sodium trimetaphosphate converts to sodium tripolyphosphate via drum drying of sodium trimetaphosphate-NaOH solutions, without forming sodium acid tripolyphosphate, with tripolyphosphate degradation increasing with excess NaOH[3].
Sodium trimetaphosphate converts to sodium tripolyphosphate in concentrated Na+OH− solutions, with tripolyphosphate stability decreasing with higher Na+OH− concentration and temperature; at 50.0°C or 70.0°C with 20% Na+OH−, tripolyphosphate remains stable, while at 35% or 50% Na+OH−, tripolyphosphate degrades to pyrophosphate and orthophosphate[3].
Sodium trimetaphosphate converts to sodium tripolyphosphate via sodium carbonate in 20% solids solutions at 70°C, with a 50% conversion time of 200 minutes, which is far slower than the 2-minute 50% conversion time with stoichiometric sodium hydroxide[3].
Sodium trimetaphosphate converts to sodium tripolyphosphate in detergent slurries with <60% solids at a rate controlled by the chemical reaction, reaching 97% conversion in 5 minutes at 100°C[3].
Sodium trimetaphosphate reacts with methyl α-D-glucopyranoside in alkaline medium (pH 10-13.5) to form crosslinked monophosphate (Pc) and grafted monophosphate (Pg) in a ~2:1 ratio via a two-step mechanism involving grafted tripolyphosphate (STPP9) as an intermediate, with reaction stopping at pH <10 and degradation dominating at pH >13.9[4].
Sodium trimetaphosphate (0.1 M) crosslinks pullulan in alkaline medium to form hydrogels containing the same phosphorylated species (P_g, P_c, STPP9) observed in the methyl α-D-glucopyranoside model system, confirming the model's validity for polysaccharide crosslinking[4].
Sodium trimetaphosphate is highly stable at pH 5.4 but undergoes immediate, temperature-dependent alkaline hydrolysis to tripolyphosphate at pH 13.5, with degradation inhibited at pH ≤11[4].
Sodium Trimetaphosphate increases the heat sensitivity of Salmonella typhimurium in peptone diluent or complex laboratory media[2].
Sodium trimetaphosphate does not inhibit planktonic Candida albicans or Streptococcus mutans at the concentrations tested in the MIC assay[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Sodium trimetaphosphate (10%; dietary; daily; 28 days) causes transient renal tubular necrosis and growth retardation in male weanling rats over 28 days, with the renal lesion resolving by study end[2].
Sodium trimetaphosphate (0.1-10.0%; dietary; daily; 2 years) causes substantial growth retardation and altered femur composition in weanling rats over 2 years, while lower doses (0.1% and 1.0%) have minimal or transient effects, and no carcinogenic potential is observed[2].
Sodium trimetaphosphate (0.05%; dietary; daily; across three generations) has no adverse effects on fertility, litter parameters, offspring development, or organ health in rats[2].
Sodium trimetaphosphate (0.5 g; topical; single 24-hour application) causes no skin irritation in albino rabbits, with a PII of 0[2].
Sodium trimetaphosphate (46-100 mg/kg; p.o.; single dose) is partially excreted in rat urine, with 40% of the dose recovered as 2% labile phosphate and 38% sodium orthophosphate[2].
Sodium trimetaphosphate (i.v.; single dose) is rapidly cleared from rabbit plasma, distributes to 12% of body weight, and causes a transient increase in urinary orthophosphate excretion that resolves within 2 hours[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Rochester (ex-Wistar) (female)[2]
-
Dosage:3650 mg/kg
-
Administration:i.p.; single dose
-
Result:Reached an intraperitoneal LD50 of 3650 mg/kg.
Caused no metabolic acidosis or hypocalcemia.
-
Animal Model:unspecified (male, weanling)[2]
-
Dosage:10%
-
Administration:dietary; daily; 28 days
-
Result:Exhibited transient tubular necrosis apparent by day 15, which resolved by day 28.
Caused retarded growth, similar to those fed 10% sodium chloride or other 10% polyphosphates.
-
Animal Model:unspecified (male, female, weanling)[2]
-
Dosage:0.1%; 1.0%; 10.0%
-
Administration:dietary; daily; 2 years
-
Result:Showed no growth retardation in 0.1% group, except for slight retardation in 1.0% males up to 6 months that resolved by the second year.
Caused substantial growth reduction in 10.0% group despite normal feed consumption at 1 and 4 months, partially attributed to a cathartic effect.
Resulted in lower red cell counts and hematocrits in high-dose female rats.
Showed only traces of reducing substances and protein in urine analysis.
Led to 88% mortality in high-dose females, 58% in low-dose females, and 70% in low-dose males, with principal causes being respiratory infection and pericarditis-peritonitis; mortality was not influenced by lower doses.
Caused increased organ weight-to-body weight ratios in high-dose rats due to growth retardation, with livers smaller than other groups.
Resulted in shorter femurs in high-dose males and females, with high-dose males having less water and more ash in femurs, and high-dose females having more water and less ash; calcium and phosphorus concentrations in femurs were increased in high-dose rats.
Caused no microscopic changes attributed to the reagent; renal collecting tubule calcification in high-dose rats was linked to nematode infection.
Showed no correlation between reagent concentration and tumor incidence.
-
Animal Model:unspecified (16 females, 8 males per group)[2]
-
Dosage:0.05%
-
Administration:dietary; daily; across three generations
-
Result:Had no effect on fertility, litter size, growth, or survival of offspring.
Caused no abnormal organ weights or microscopic changes in third-generation rats.
-
Animal Model:Albino[2]
-
Dosage:0.5 g
-
Administration:topical; single 24-hour application
-
Result:Achieved a primary irritation index (PII) of 0, classifying it as a nonirritant to rabbit skin.
-
Animal Model:Albino (male, fasted)[2]
-
Dosage:46 mg/kg; 100 mg/kg
-
Administration:p.o.; single dose
-
Result:Led to 40% of the dose being excreted in urine, with 2% as labile phosphate and 38% as sodium orthophosphate.
Chemical Information
-
CAS No. 7785-84-4
-
Appearance Solid
-
Molecular Weight 305.89
-
Formula Na3P3O9
-
SMILES
[Na][Na].[Na]P(P(=O)=O)(OO[O])(O[O])P(=O)=O
-
Synonyms
Trisodium cyclo-triphosphate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature, keep dry and cool
In solvent -80°C 1 year -20°C 6 months
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)